Palborest 75mg Tablet
By Palborest
Rx
21 Tablet in a Boxes

Composition
Palbociclib(75mg)

Manufacturer - MSN Laboratories
MSN House, Plot No: C-24, Industrial Estate, Sanathnagar, Hyderabad - 18 Telangana, INDIA

Expires on or after
July, 2025

liver
When using Palborest 75mg Tablet, it is important to exercise caution if you have liver disease. Patients with liver issues may require a dose adjustment when taking Palborest 75mg Tablet. It is advised to consult your doctor regarding the use of this medication to ensure proper management and safety.

kidney
Palborest 75mg Tablet is safe for use in individuals with kidney disease, and no dose adjustment is needed.

alcohol
Consult your doctor when consuming alcohol with Palborest 75mg Tablet.

driving
Palborest 75mg Tablet can cause fatigue, affecting driving ability. Use caution if feeling tired, to ensure safe driving or machine operation.

pregnancy
Palborest 75mg Tablet is considered unsafe during pregnancy due to a definite risk to the developing baby. In exceptional life-threatening situations, a doctor may prescribe it if the benefits outweigh the potential risks. It is crucial to consult your doctor before using this medication during pregnancy.

breastfeeding
Palborest 75mg Tablet is not recommended for use during breastfeeding as it may be harmful to the baby, possibly causing toxicity.
Habit Forming | No |
Chemical Class | Pyridinylpiperazines |
Therapeutic Class | - |
Action Class | Cyclin-Dependent Kinase Inhibitor |
₹4500
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025